GEODIS CL PHARMA
SIREN 399170679
No insolvency procedure
No collective procedure published in the BODACC window loaded by Solvenda. Monitoring continues daily.
Index compliant
- Score published : 91/100 (edition 2025)
- Headcount band : 50 à 250
- Sector : Transports et entreposage
- Department : Eure
Source: Gender Equality Index published by the French Ministry of Labour, Open Licence 2.0. Absence from an edition may also mean the company left the obligation.
2 agreement(s) filed, 2 with a term date
| Agreement | Theme | Term |
|---|---|---|
| UN ACCORD RELATIF AUX NEGOCIATIONS ANNUELLES OBLIGATOIRES (NAO) AU TITRE DE L'ANNEE 2026 | Evolution des salaires (augmentation, gel, diminution) | 199 days (2027-03-17) |
| UN ACCORD SUR LES MODALITES DE LA NEGOCIATION ANNUELLE OBLIGATOIRE 2026 | Autre, précisez | expired 2026-03-31 |
Source: ACCO database of company agreements, DILA and Légifrance, Open Licence 2.0.
Solvenda watches for you, every morning.
Monitor this SIREN and your whole portfolio automatically.
Get started Risk index →Frequently asked questions
Is GEODIS CL PHARMA in insolvency proceedings?
No collective procedure is published in the BODACC for SIREN 399170679 in the window loaded by Solvenda. This is not a solvency guarantee; monitoring continues daily.
Does the absence of a BODACC procedure guarantee solvency?
No. It only proves no insolvency procedure is published to date. Continuous monitoring by SIREN remains necessary.
What is the gender equality index of GEODIS CL PHARMA?
GEODIS CL PHARMA published a score of 91 for the 2025 edition. Below 75, a company has three years to correct, failing which a penalty of up to 1% of payroll may apply.
Does GEODIS CL PHARMA have collective agreements?
2 company agreement(s) filed by GEODIS CL PHARMA appear in the public ACCO database, of which 1 reach their term within twelve months.